5-fluorodopamine has been researched along with fluorodopa f 18 in 10 studies
| Studies (5-fluorodopamine) | Trials (5-fluorodopamine) | Recent Studies (post-2010) (5-fluorodopamine) | Studies (fluorodopa f 18) | Trials (fluorodopa f 18) | Recent Studies (post-2010) (fluorodopa f 18) |
|---|---|---|---|---|---|
| 76 | 8 | 16 | 803 | 49 | 307 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, HR; Channing, MA; Dunn, BB; Goldstein, DS; Kiesewetter, DO; Kirk, KL | 1 |
| Chirakal, R; Firnau, G; Garnett, ES; Nahmias, C; Sood, S | 2 |
| Loc'h, C; Mazière, B; Wang, RF | 1 |
| Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Merino, MJ; Pacak, K; Seidel, J; Thomasson, D | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
| Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y | 1 |
| Chen, X; Cleary, S; Dawson, LF; Eisenhofer, G; Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Pacak, K; Phillips, JK; Powers, JF; Seidel, J; Thomasson, D | 1 |
| Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K | 1 |
| Blanchet, EM; Bluemke, DA; Maass-Moreno, R; Martucci, V; Millo, C; Pacak, K | 1 |
1 trial(s) available for 5-fluorodopamine and fluorodopa f 18
| Article | Year |
|---|---|
Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.
Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Injections; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; National Institutes of Health (U.S.); Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed; United States; Whole Body Imaging | 2014 |
9 other study(ies) available for 5-fluorodopamine and fluorodopa f 18
| Article | Year |
|---|---|
A single column, rapid quality control procedure for 6-[18F]fluoro-L-dopa and 6-[18F]fluorodopamine PET imaging agents.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Quality Control; Tomography, Emission-Computed | 1991 |
Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate.
Topics: Animals; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Kinetics; Levodopa; Macaca mulatta; Male; Occipital Lobe | 1987 |
Metabolites of 6-[18F]fluoro-L-dopa in human blood.
Topics: Adult; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Homovanillic Acid; Humans; Middle Aged | 1988 |
Determination of unchanged [18F]dopamine in human and non-human primate plasma during positron emission tomography studies: a new solid-phase extraction method comparable to radio-thin-layer chromatography analysis.
Topics: Adult; Aluminum Oxide; Animals; Chromatography, Thin Layer; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Haplorhini; Humans; Male; Middle Aged; Reproducibility of Results; Tomography, Emission-Computed | 1997 |
Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.
Topics: Adrenal Gland Neoplasms; Animals; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Mice, Nude; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; Dopamine; Dopaminergic Neurons; Gait Disorders, Neurologic; Hallucinations; Humans; Lewy Body Disease; Male; Neostriatum; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Shy-Drager Syndrome; Sympathetic Nervous System | 2012 |
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Female; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Neoplasms, Experimental; Norepinephrine Plasma Membrane Transport Proteins; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins | 2012 |
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers | 2013 |